Harrow (HROW) Earnings Date & Reports

Harrow Inc is anÂ eyecare pharmaceutical company engaged in the discovery, development, and commercialization ofÂ ophthalmic pharmaceutical products for the U... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

HROW is expected to report earnings to fall 77.08% to 5 cents per share on May 19

Q1'25

Est.

$0.05

Q4'24

Beat

by $0.11

Q3'24

Missed

by $0.07

Q2'24

Beat

by $0.12

Q1'24

Missed

by $0.08

The last earnings report on March 27 showed earnings per share of 23 cents, beating the estimate of 13 cents. With 1.70M shares outstanding, the current market capitalization sits at 467.85M.

View a ticker or compare two or three

Compare

HROW